162
P.W. Davies, N. Martin / Journal of Organometallic Chemistry 696 (2011) 159e164
7.24e7.27 (m, 3H), 7.30 (s, 5H), 7.34 (d, J ¼ 8.3 Hz, 2H), 7.89 (d,
2230, 1830, 1630, 1323, 1160, 1093, 980, 940, 876, 725; HRMS (TOF
ESþ): m/z calcd for C17H21NO2NaS: 326.1191, found: 326.1182.
J ¼ 8.3 Hz, 2H); 13C NMR (75 MHz, CDCl3):
d
¼ 20.8, 21.7, 34.4, 36.2,
46.1, 73.0, 85.9, 126.2, 127.8 (2C), 127.9 (2C), 128.0 (2C), 128.3 (5C),
129.8 (2C), 132.2, 134.8, 140.2, 144.8; IR (neat):
n
¼ 2987, 2931, 2248,
4.2.7. 2-Isopropyl-1-(toluene-4-sulfonyl)-3-((trimethylsilyl)
ethynyl)aziridine (4a)
1597, 1495, 1453, 1384, 1327, 1291, 1233, 1158, 1090, 1021, 875, 814,
742, 695; HRMS (TOF ESþ): m/z calcd for C25H23NO2NaS: 424.1347,
found: 424.1341.
Colourless oil (70%, cis isomer only). 1H NMR (300 MHz, CDCl3):
d
¼ 0.12 (s, 9H), 0.79 (d, J ¼ 6.8 Hz, 3H), 0.98 (d, J ¼ 6.8 Hz, 3H),
1.50e1.60 (m, 1H), 2.45 (s, 3H), 2.49 (dd, J ¼ 6.9, 2.6 Hz, 1H), 3.38 (d,
4.2.2. 2-((4-Bromophenyl)ethynyl)-3-phenyl-1-(toluene-4-
sulfonyl)aziridine (Table 1, Entry 8)
J ¼ 6.9 Hz, 1H), 7.34 (d, J ¼ 8.3 Hz, 2H), 7.84 (d, J ¼ 8.3 Hz, 2H); 13C
NMR (75 MHz, CDCl3):
d
¼ ꢁ0.4 (3C), 18.4, 20.1, 21.7, 28.4, 33.9, 51.0,
Colourless oil (75%, 15:1 cis:trans). 1H NMR (300 MHz, CDCl3):
90.0, 97.9, 128.2 (2C), 129.6 (2C), 134.6, 144.7; IR (neat):
n
¼ 2966,
d
¼ 2.43 (s, 3H), 3.85 (d, J ¼ 6.9 Hz, 1H), 4.09 (d, J ¼ 6.9 Hz, 1H), 7.02
2913, 2178, 1601, 1472, 1405, 1351, 1322, 1308, 1291, 1250, 1154,
1092, 1076, 945, 873, 840, 814, 759; HRMS (TOF ESþ): m/z calcd for
C17H25NO2NaSSi: 358.1273, found: 358.1281.
(d, J ¼ 8.6 Hz, 2H), 7.36e7.31 (m, 9H), 7.92 (d, J ¼ 8.3 Hz, 2H); 13C
NMR (75 MHz, CDCl3):
127.1, 128.0 (2C), 128.3 (2C), 128.6 (2C), 129.4 (2C), 131.5 (2C), 134.7
(2C), 136.9, 137.8, 138.4; IR (neat):
d
¼ 21.7, 26.9, 42.2, 80.0, 92.3, 121.9, 123.1,
n
¼ 3066, 2233, 1599, 1450, 1334,
4.2.8. 2-Isopropyl-1-(toluene-4-sulfonyl)-3-((triethylsilyl)ethynyl)
aziridine (4d)
1233, 1160, 1087, 1023, 885, 818, 745, 698; HRMS (TOF ESþ): m/z
calcd for C23H18NO2NaSBr: 474.0139, found: 474.0145.
Colourless oil (80%, cis isomer only). 1H NMR (300 MHz, CDCl3):
d
¼ 0.55 (q, J ¼ 8.0 Hz, 6H), 0.81 (d, J ¼ 6.7 Hz, 3H), 0.93 (t, J ¼ 8.0 Hz,
4.2.3. 2-Butyl-3-(phenylethynyl)-1-(toluene-4-sulfonyl)aziridine
(Table 1, Entry 9)
9H), 0.98 (d, J ¼ 6.7 Hz, 3H), 1.58e1.65 (m, 1H), 2.44 (s, 3H), 2.51 (dd,
J ¼ 9.7, 6.9 Hz,1H), 3.37 (d, J ¼ 6.9 Hz,1H), 7.33 (d, J ¼ 8.3 Hz, 2H), 7.83
Colourless oil (40%, cis isomer only). 1H NMR (300 MHz, CDCl3):
(d, J ¼ 8.3 Hz, 2H); 13C NMR (75 MHz, CDCl3):
¼ 4.1 (3C), 7.3 (3C),
d
d
¼ 0.84 (t, J ¼ 7.0 Hz, 3H), 1.26e1.32 (m, 4H), 1.55e1.75 (m, 2H),
18.5, 20.2, 21.7, 28.5, 34.0, 51.0, 87.5, 99.0,128.1 (2C),129.6 (2C),134.7,
2.44 (s, 3H), 2.63 (dt, J ¼ 13.0, 6.9 Hz, 1H), 3.59 (d, J ¼ 6.9,
144.6; IR (neat):
n
¼ 3047, 2958, 2875, 2230, 1323, 1160, 1093, 876,
1H),7.28e7.41 (m, 7H), 7.87 (d, J ¼ 8.3 Hz, 2H); 13C NMR (75 MHz,
725; HRMS (TOF ESþ): m/z calcd for C20H31NO2NaSSi: 400.1742,
CDCl3):
d
¼ 13.8, 21.6, 22.1, 27.9, 28.7, 34.4, 45.3, 82.0, 84.2,
found: 400.1733.
121.9, 128.0 (2C), 128.2, 128.8 (2C), 129.7 (2C), 131.9 (2C),
134.7, 144.7; IR (neat):
1304,1292,1152, 1087, 934, 842, 809, 753, 730, 715, 688, 672; HRMS
n
¼ 2965, 2930, 2860, 2249, 1601, 1491, 1316,
4.2.9. 2-Deuterio-3-hex-1-ynyl-1-(toluene-4-sulfonyl)-2-p-
tolylaziridine (6)
(TOF ESþ): m/z calcd for C21H23NO2NaS: 376.1347, found: 376.1340.
Colourless oil (77%, 12:1 cis:trans). 1H NMR (300 MHz, CDCl3):
d
¼ 0.76 (t, J ¼ 7.2 Hz, 3H), 1.05e1.18 (m, 2H), 1.22e1.31 (m, 2H), 2.02
4.2.4. 2-Cyclohexyl-3-(cyclohexylethynyl)-1-(toluene-4-sulfonyl)
aziridine (Table 1, Entry 12)
(dt, J ¼ 6.9 Hz, 1.8 Hz, 2H), 2.32 (s, 3H), 2.43 (s, 3H), 3.60 (t,
J ¼ 1.8 Hz,1H), 7.09 (d, J ¼ 8.1 Hz, 2H), 7.21 (d, J ¼ 8.1 Hz, 2H), 7.33 (d,
J ¼ 8.4 Hz, 2H), 7.87 (d, J ¼ 8.4 Hz, 2H); 13C NMR (75 MHz, CDCl3):
Colourless oil (51%, 25:1 cis:trans). 1H NMR (300 MHz, CDCl3):
d
¼ 0.85e1.15 (m, 5H), 1.24e1.43 (m, 9H), 1.59e1.78 (m, 8H), 2.43 (s,
d
¼ 13.4, 18.3, 21.2, 21.5, 21.6, 30.0, 36.1, 72.3, 86.6, 127.6 (2C), 127.9
3H), 2.53 (dd, J ¼ 9.6, 6.9 Hz, 1H), 3.35 (dd, J ¼ 6.9, 1.5 Hz, 1H), 7.31
(2C), 128.6 (2C), 129.1, 129.7 (2C), 134.8, 138.0, 144.6; IR (neat):
(d, J ¼ 8.3 Hz, 2H), 7.81 (d, J ¼ 8.3 Hz, 2H); 13C NMR (75 MHz,
n
¼ 2961, 2926, 2874, 2248, 1921, 1598, 1518, 1458, 1410, 1363, 1323,
CDCl3):
d
¼ 21.6, 24.4 (2C), 25.3, 25.4, 25.7, 26.0 (2C), 28.8, 29.0, 32.0
1301, 1181, 1161, 1133, 1090, 1019, 914, 894, 838, 805, 757, 704;
HRMS (TOF ESþ): m/z calcd for C22H24DNO2NaS: 391.1566, found:
391.1563.
(2C), 33.8, 37.2, 49.4, 72.8, 88.9, 128.0 (2C), 129.5 (2C), 134.7, 144.5;
IR (neat):
n
¼ 2967, 2871, 2249, 1598, 1448, 1319, 1153, 1192, 815,
709, 686; HRMS (TOF ESþ): m/z calcd for C23H31NO2NaS: 408.1973,
found: 408.1976.
4.3. Pyrroles
4.2.5. 2-(Cyclohexylethynyl)-3-isopropyl-1-(toluene-4-sulfonyl)
aziridine (Table 1, Entry 13)
4.3.1. General Method for gold-catalysed cyclisation
The catalyst system is prepared by addition of anhydrous 1,2-
dichloroethane (0.5 mL) to Ph3PAuCl (0.01 mmol, 5.0 mg) and AgOTs
(0.01 mmol, 2.8 mg). After stirring for 10 min at room temperature,
a white precipitate of AgCl is observed and a solution of the corre-
sponding acetylenyl aziridine (0.2 mmol) in anhydrous 1,2-dichlo-
roethane (0.5 mL) was added. The reaction mixture was stirred at the
indicated temperature until complete consumption of aziridine was
observed. The solution was filtered through a pad of silica and then
concentrated under reduced pressure to afford the pyrrole.
Colourless oil (50%, 15:1 cis:trans). 1H NMR (300 MHz, CDCl3):
d
¼ 0.77 (d, J ¼ 6.7 Hz, 3H), 0.96 (d, J ¼ 6.7 Hz, 3H), 1.24e1.48 (m,
6H), 1.54e1.80 (m, 5H), 2.44e2.37 (m, 5H), 3.37 (dd, J ¼ 6.9, 1.3 Hz,
1H), 7.31 (d, J ¼ 8.2 Hz, 2H), 7.81 (d, J ¼ 8.2 Hz, 2H); 13C NMR
(75 MHz, CDCl3):
d
¼ 18.5, 20.1, 21.6, 24.5 (2C), 25.7, 28.3, 32.1 (2C),
34.1 (2C), 50.9, 72.6, 89.1, 128.0 (2C), 129.5 (2C), 134.7, 144.5; IR
(neat):
1151, 1088, 946, 899, 876, 866, 813, 801, 775; HRMS (TOF ESþ): m/z
n
¼ 2965, 2927, 2854, 2241, 1598, 1449, 1406, 1314, 1304,
calcd for C20H27NO2NaS: 368.1660, found: 368.1666.
4.3.2. 2-2-Phenethyl-5-phenyl-1-(toluene-4-sulfonyl)-1H-pyrrole
(Table 1, Entry 7)
4.2.6. 2-Isopropyl-3-(pent-4-en-1-ynyl)-1-(toluene-4-sulfonyl)
aziridine (Table 1, Entry 15)
Colourless oil (95%). 1H NMR (300 MHz, CDCl3):
d
¼ 2.38 (s, 3H),
Colourless oil (40%, cis isomer only). 1H NMR (300 MHz, CDCl3):
3.05e3.10 (m, 2H), 3.23e3.28 (m, 2H), 6.06 (d, J ¼ 3.3 Hz, 1H), 6.09
d
¼ 0.81 (d, J ¼ 6.7 Hz, 3H), 0.99 (d, J ¼ 6.7 Hz, 3H), 1.58e1.69 (m,
(d, J ¼ 3.3 Hz,1H), 7.15 (d, J ¼ 8.3 Hz, 2H), 7.21e7.33 (m, 7H), 7.35 (m,
1H), 2.45 (s, 3H), 2.52 (dd, J ¼ 9.8, 6.9 Hz, 1H), 2.95 (dd,
J ¼ 5.2, 1.8 Hz, 2H), 3.41 (dt, J ¼ 6.9, 1.8 Hz, 1H), 5.09 (dd, J ¼ 10.0,
1.7 Hz, 1H), 5.23 (dd, J ¼ 17.0, 1.7 Hz, 1H), 5.70e5.79 (m, 1H), 7.34 (d,
J ¼ 8.3 Hz, 2H), 7.84 (d, J ¼ 8.3 Hz, 2H); 13C NMR (75 MHz, CDCl3):
5H); 13C NMR (75 MHz, CDCl3):
d
¼ 21.6, 31.8, 36.3, 113.5, 115.6,
126.0, 126.4 (2C), 127.2 (2C), 127.8, 128.3 (2C), 128.5 (2C), 129.3 (2C),
130.5 (2C),133.2,136.2,138.4,138.8, 141.5,144.3; IR (neat):
n
¼ 3027,
2920, 2851,1596,1494,1452,1363,1295,1170,1098,1071,1028, 908,
809, 759, 729, 694; HRMS (TOF ESþ): m/z calcd for C25H23NO2NaS:
424.1347, found: 424.1340.
d
¼ 18.6, 20.1, 21.6, 23.0, 28.3, 34.0, 51.0, 76.4, 81.6, 116.3, 128.1 (2C),
129.6 (2C), 131.7, 134.7, 144.7; IR (neat):
n
¼ 3089, 3047, 2958, 2875,